Neurological Complications of COVID-19: Guillain-Barre Syndrome Following Pfizer COVID-19 Vaccine
- PMID: 33758714
- PMCID: PMC7978140
- DOI: 10.7759/cureus.13426
Neurological Complications of COVID-19: Guillain-Barre Syndrome Following Pfizer COVID-19 Vaccine
Abstract
Since the first case of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was reported in Wuhan, China, in December 2019, Coronavirus - 19 (COVID-19) has become a global pandemic with multiple neurological complications. In December 2020, two vaccines have been approved in the United States for the prevention of COVID-19. We report a case of Guillain-Barre Syndrome (GBS) after receiving the first dose of Pfizer - COVID-19 vaccine.
Keywords: covid-19 vaccine; guillain-barre syndrome (gbs); neurologic complications.
Copyright © 2021, Waheed et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- Looking beyond COVID-19 vaccine phase 3 trials. Kim JH, Marks F, Clemens JD. Nat Med. 2021;19:1–7. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous